Clinical trials of coronavirus vaccine made in India started on humans

New Dehli – India’s first vaccine for the prevention of coronavirus infection, COVAXIN’s clinical trials on humans started at AIIMS Hospital in Delhi. In the first phase of testing, the Covaxin would be given to 375 volunteers. This vaccine will be tested on 100 volunteers in the AIIMS Hospital and the trials on the remaining 275 volunteers will be conducted in other centres of the country. This vaccine will be given only to the first 50 volunteers out of 100 volunteers of AIIMS. If the findings of this test are found affirmative, the details of this test will be sent to the data committee of ICMR. According to this test, if everything goes well, this vaccine will be given to other volunteers.

AIIMS on Monday, announced that it will start screening volunteers for phase-1 testing of the indigenous #COVID19 vaccine, Covaxin, , on healthy persons aged 18-55, without co-morbidities https://t.co/Aq2ZBUoxJM

— The Hindu (@the_hindu) July 21, 2020

Hyderabad’s Bharat Biotech jointly with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV) have developed the Covaxin vaccine. The generic name of this vaccine is BVB-152.